Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants - Wikidata - awgldk - TriplyDB

Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants

Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants

http://www.wikidata.org/entity/Q24626231

about

Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology Intestinal fatty-acid binding protein and metronidazole response in premature infants Dosing in neonates: special considerations in physiology and trial design.Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct.Adverse consequences of neonatal antibiotic exposure New antibiotic dosing in infants.Pharmacokinetic studies in infants using minimal-risk study designs Solithromycin Pharmacokinetics in Plasma and Dried Blood Spots and Safety in Adolescents.Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience.The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants.Dosing antibiotics in neonates: review of the pharmacokinetic data.Development of Floating-Mucoadhesive Microsphere for Site Specific Release of Metronidazole.Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling.LC-MS determination of triazolam and its hydroxy metabolites in mouse dried blood spots: application to transgenic mouse pharmacokinetic studies.Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation.Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in Neonates.Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.

P2860

Q33827819-CB0BB00D-8B21-4FD3-8D60-5B495F536F43 Q34476223-D1F74295-B618-4AFD-B2F0-D0D36B43DAEB Q34716879-A4D32CE4-5997-48FB-A78C-D584122F2C3F Q35135932-88E150D0-EDDE-4117-A4A9-142AA24DFD2A Q35926313-AB3D0E74-5904-4F8C-9C08-BC339289F7D8 Q36438111-00A8B5CC-CF8C-4BE5-8DEB-61C2E381111E Q36438116-6359D08D-ADFF-4B39-AD4F-4E6088DF6FB5 Q36730079-95E347DC-3AFA-490A-8707-E00BAD02B6DE Q37203671-DFDE727E-EC03-4FC2-8B25-8499A7FE40DC Q37422732-3EFD3C28-1D06-445A-AE6B-31352E50A777 Q37713019-5A46BA9B-9EDE-472F-B938-C999499056B1 Q38649419-9AC40EB1-ECAB-4A60-B984-2E72EA978D9B Q40593275-C631AE8B-99D9-44FD-9799-B505522E7410 Q40772216-E218F73D-CFBA-4AA7-A65C-5AB11ADA692C Q47977705-348F2959-1270-40A4-B712-4A77E015BDC4 Q47982489-2402A81B-10EB-4E0D-B55B-BC95DC7A5E0C Q48559800-DDF3E7E4-9479-4908-8978-E8639A6CD896 Q50468318-70DE74A4-18DD-4A67-959E-45008F11DAB2

P2860

Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants

http://www.wikidata.org/entity/Q24626231

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Determining population and dev ...... samples from premature infants

@ast

Determining population and dev ...... samples from premature infants

@en

Determining population and dev ...... samples from premature infants

@nl

type

label

Determining population and dev ...... samples from premature infants

@ast

Determining population and dev ...... samples from premature infants

@en

Determining population and dev ...... samples from premature infants

@nl

prefLabel

Determining population and dev ...... samples from premature infants

@ast

Determining population and dev ...... samples from premature infants

@en

Determining population and dev ...... samples from premature infants

@nl

P1433

Q24626231-9C68C792-4522-45A0-9317-05683E3304BA

P1476

Q24626231-8B6A9692-B7DC-4C51-B277-AE79774D3F1B

P2093

Q24626231-2F02A863-C3C3-4B48-A21D-E62E3874264A

Q24626231-3D7DCFC6-CECB-4EFD-8985-552695FCB5BC

Q24626231-3D9883F0-0B6B-4583-BAF5-03DDC2EC2E38

Q24626231-48BABBE4-A993-4A37-A385-F0C95256A897

Q24626231-76713D32-28C8-42E9-BEE2-ADE720EBE8D8

Q24626231-8442EECD-4F47-4D77-A662-F01B53B95083

Q24626231-8E8652D6-1DEE-42C4-BAC8-DB969CFD9FB8

Q24626231-8EBA2814-09A8-4325-8E47-7B58CF596720

Q24626231-AC529465-E00F-4343-89C7-F1E272DEC267

Q24626231-D243621F-E0E0-4C77-8477-3ECBB535D344

P2860

Q24626231-096E1B66-CF1A-47CF-B0DE-3A39B3C86281

Q24626231-0F7E246B-D228-4E0B-8B30-9C39A5155E38

Q24626231-1E9E856B-FB4D-4234-8F82-A2471993FE2A

Q24626231-30B234A7-BEC0-426A-B88E-161CF80D218D

Q24626231-43D910F2-4766-4B7C-ACD3-50BD28F02D34

Q24626231-55E46DDC-9C59-4DC0-A3D5-F81A2B7AB46A

Q24626231-7501B8CB-558A-48B4-9AB0-389E425DB5DD

Q24626231-7E0EAABF-BB48-449C-83F1-6AE693704F8E

Q24626231-8EAC09AF-AADF-488C-8195-619F11BE7698

Q24626231-AC2CB1FC-D598-46F2-90A2-D3BF671A42AD

P304

Q24626231-D0918FA9-70D2-4D9F-8B18-F6A119E1F687

P31

Q24626231-7D6B5580-54B3-4959-998A-51652B054B7D

P356

Q24626231-43958031-2352-47CC-89C5-C91E1893B435

P407

Q24626231-015D9C2C-0E32-46A5-BAF9-F964B0A67230

P433

Q24626231-83AEB7F7-ED13-4D89-BEB2-32EBCC45ADB5

P478

Q24626231-98CF1550-F691-4A83-B7DA-922E617F5B78

P577

Q24626231-4EB3F9CA-D07F-4B87-91F6-273663129E46

P698

Q24626231-EFC9FBCE-0896-45A2-AEAF-47835BE56A24

P921

Q24626231-23168D5B-23BA-4F8A-AD3A-752D72CB2489

Q24626231-57C5D3B3-24C6-413A-8B68-416E78863833

P932

Q24626231-8FF13A46-026B-4DC9-B5C8-AE55B7FC9248

P356

INF.0B013E3182947CF8

P1433

Pediatric Infectious Disease Journal

P1476

Determining population and dev ...... samples from premature infants

@en

P2093

Antonio Arrieta

http://www.w3.org/2001/XMLSchema#string

Barrie Harper

http://www.w3.org/2001/XMLSchema#string

Barry T Bloom

http://www.w3.org/2001/XMLSchema#string

Daniel K Benjamin

http://www.w3.org/2001/XMLSchema#string

David Siegel

http://www.w3.org/2001/XMLSchema#string

Edmund V Capparelli

http://www.w3.org/2001/XMLSchema#string

Gregory L Kearns

http://www.w3.org/2001/XMLSchema#string

James L Wynn

http://www.w3.org/2001/XMLSchema#string

Karen Martz

http://www.w3.org/2001/XMLSchema#string

Mario Sampson

http://www.w3.org/2001/XMLSchema#string

P2860

Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections

Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.

Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants

Necrotizing enterocolitis in newborns: pathogenesis, prevention and management.

Bacteremia due to anaerobic bacteria in newborns.

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience.

Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994.

I.V. acetaminophen pharmacokinetics in neonates after multiple doses.

Model appropriateness and population pharmacokinetic modeling.

P304

956-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/INF.0B013E3182947CF8

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23587979

http://www.w3.org/2001/XMLSchema#string

P921

pharmacokinetics

P932

3769518

http://www.w3.org/2001/XMLSchema#string